Безопасен ли hydrogenated tallowamide dea при беременности?
No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
Related ingredients
Frequently asked questions
- Безопасен ли hydrogenated tallowamide dea при беременности?
- No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
- Безопасен ли hydrogenated tallowamide dea при грудном вскармливании?
- Same evidence basis as for pregnancy: no harmonised classification or specific reproductive/developmental toxicity data were located for this CAS. Theoretical class concerns about DEA‑type substances (e.g., formation of nitrosamines or residual free DEA) are noted in broader DEA discussions but are not specific toxicological proof for this substance. Dermal exposure from cosmetics is low‑to‑measurable; breastfeeding exposure via milk is not demonstrated in the literature for this ingredient.
- Безопасен ли hydrogenated tallowamide dea для кожи малыша?
- No infant‑specific reproductive or developmental data were identified. Infant skin has higher surface‑area‑to‑weight and immature barrier function, so exposure score is increased by +1 relative to adult (adult e=1 → infant e=2) despite lack of data showing systemic effects. No evidence found that the ingredient is banned/restricted for infant use under EU Cosmetic Regulation.
- Как VeriMom оценивает hydrogenated tallowamide dea?
- VeriMom оценивает hydrogenated tallowamide dea в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы hydrogenated tallowamide dea при беременности?
- См. наш список безопасных альтернатив hydrogenated tallowamide dea с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.